Urinary Sodium and Potassium, and Risk of Ischemic and Hemorrhagic Stroke (INTERSTROKE): A Case-Control Study

Primer Autor
Judge, Conor
Título
Urinary Sodium and Potassium, and Risk of Ischemic and Hemorrhagic Stroke (INTERSTROKE): A Case-Control Study
Editorial
OXFORD UNIV PRESS
Revista
AMERICAN JOURNAL OF HYPERTENSION
Lenguaje
en
Tipo de Recurso
artículo original
Derecho de Acceso
acceso abierto
Description
The INTERSTROKE study is funded by the Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada, Canadian Stroke Network, Swedish Research Council, Swedish Heart and Lung Foundation, The Health & Medical Care Committee of the Regional Executive Board, Region Vastra Gotaland, and through unrestricted grants from several pharmaceutical companies with major contributions from Astra Zeneca, Boehringer Ingelheim (Canada), Pfizer (Canada), MERCK, Sharp and Dohme, Swedish Heart and Lung Foundation, UK Chest, and UK Heart and Stroke. C.J. was funded by Wellcome TrustHealth Research Board Irish Clinical Academic Training (ICAT). M.O.D. was funded by European Research Council COSIP Grant 640580.
doi
10.1093/ajh/hpaa176
Formato Recurso
pdf
Palabras Claves
blood pressure
hypertension
intracerebral hemorrhage
ischemic stroke
potassium
sodium
stroke
Ubicación del archivo
Categoría OCDE
Enfermedad vascular periférica
Materias
presión arterial
hipertensión
hemorragia intracerebral
accidente cerebrovascular isquémico
potasio
sodio
accidente cerebrovascular
Disciplinas de la OCDE
Enfermedades del sistema vascular perferico
Id de Web of Science
WOS:000672271200019
Access Rights
acceso abierto
Derechos de acceso
acceso abierto
Título de la cita (Recomendado-único)
Urinary Sodium and Potassium, and Risk of Ischemic and Hemorrhagic Stroke (INTERSTROKE): A Case-Control Study
Identificador del recurso (Mandatado-único)
artículo original
Versión del recurso (Recomendado-único)
version publicada
Editorial
OXFORD UNIV PRESS
Revista/Libro
AMERICAN JOURNAL OF HYPERTENSION
Categoría WOS
Enfermedad vascular periférica
Idioma
en
ISSN
0895-7061
Descripción
The INTERSTROKE study is funded by the Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada, Canadian Stroke Network, Swedish Research Council, Swedish Heart and Lung Foundation, The Health & Medical Care Committee of the Regional Executive Board, Region Vastra Gotaland, and through unrestricted grants from several pharmaceutical companies with major contributions from Astra Zeneca, Boehringer Ingelheim (Canada), Pfizer (Canada), MERCK, Sharp and Dohme, Swedish Heart and Lung Foundation, UK Chest, and UK Heart and Stroke. C.J. was funded by Wellcome TrustHealth Research Board Irish Clinical Academic Training (ICAT). M.O.D. was funded by European Research Council COSIP Grant 640580.
Referencia del Financiador (Mandatado si es aplicable-repetible)
CIHR
Heart and Stroke Foundation
Canadian Stroke Network
Swedish Research Council
Swedish Heart and Lung Foundation
Health & Medical Care Committee of the Regional Executive Board
Astra Zeneca
Boehringer Ingelheim
Pfizer
MERCK
Sharp and Dohme
UK Heart and Stroke
Wellcome Trust
ICAT
COSIP 640580
Region Vastra Gotaland
UK Chest
ERC 640580
Tipo de ruta
dorada
verde
Formato
pdf
Revisa las metricas alternativas de Almetrics
Revisa las citaciones de Dimensions